BRPI0416063A - transdermally drug delivery composition, method of producing the transdermally drug delivery composition and flow control method of a medicament of a dermal drug delivery composition - Google Patents
transdermally drug delivery composition, method of producing the transdermally drug delivery composition and flow control method of a medicament of a dermal drug delivery compositionInfo
- Publication number
- BRPI0416063A BRPI0416063A BRPI0416063-0A BRPI0416063A BRPI0416063A BR PI0416063 A BRPI0416063 A BR PI0416063A BR PI0416063 A BRPI0416063 A BR PI0416063A BR PI0416063 A BRPI0416063 A BR PI0416063A
- Authority
- BR
- Brazil
- Prior art keywords
- drug delivery
- delivery composition
- transdermally
- medicament
- flow control
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Abstract
"COMPOSIçãO DE ADMINISTRAçãO DE MEDICAMENTO POR VIA TRANSDéRMICA, MéTODO DE PRODUZIR A COMPOSIçãO DE ADMINISTRAçãO DE MEDICAMENTO POR VIA TRANSDéRMICA E MéTODO DE CONTROLE DO FLUXO DE UM MEDICAMENTO DE UMA COMPOSIçãO DE ADMINISTRAçãO DE MEDICAMENTO DéRMICA". Um sistema de administração por via transdérmica é fornecido para a aplicação tópica de um ou mais agentes ativos contidos em uma ou mais camadas portadoras poliméricas e/ou adesivas, adjacentes a um revestimento polimérico e/ou adesivo contendo nenhum medicamento que é aplicado ao forro ou suporte do sistema transdérmico. O dispositivo de administração transdérmico é fabricado para otimizar o carregamento de medicamento enquanto fornece adesão desejável a pele ou mucosa assim como fornece modulação da administração e perfil do medicamento."TRANSDERMIC DRUG ADMINISTRATION COMPOSITION, METHOD OF PRODUCTING TRANSDERMIC DRUG ADMINISTRATION AND MEDICINAL PRODUCT FLOW CONTROL METHOD". A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and / or adhesive carrier layers adjacent to a polymeric coating and / or adhesive containing no medicament that is applied to the liner or transdermal patch support. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to the skin or mucosa as well as modulating drug delivery and profile.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51530603P | 2003-10-28 | 2003-10-28 | |
PCT/US2004/035556 WO2005042055A2 (en) | 2003-10-28 | 2004-10-28 | Transdermal drug delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416063A true BRPI0416063A (en) | 2007-01-02 |
Family
ID=34549389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416063-0A BRPI0416063A (en) | 2003-10-28 | 2004-10-28 | transdermally drug delivery composition, method of producing the transdermally drug delivery composition and flow control method of a medicament of a dermal drug delivery composition |
Country Status (19)
Country | Link |
---|---|
US (3) | US8703175B2 (en) |
EP (1) | EP1682061B1 (en) |
JP (2) | JP2007509951A (en) |
KR (1) | KR20060114338A (en) |
CN (1) | CN100457064C (en) |
AU (1) | AU2004285505B2 (en) |
BR (1) | BRPI0416063A (en) |
CA (1) | CA2542778C (en) |
ES (1) | ES2626784T3 (en) |
GE (1) | GEP20084561B (en) |
IL (1) | IL174894A0 (en) |
ME (2) | MEP23508A (en) |
NO (1) | NO20062434L (en) |
NZ (1) | NZ546992A (en) |
RS (1) | RS20060332A (en) |
RU (1) | RU2356580C2 (en) |
UA (1) | UA84303C2 (en) |
WO (1) | WO2005042055A2 (en) |
ZA (1) | ZA200603300B (en) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60017831T3 (en) * | 1999-01-14 | 2009-12-17 | Noven Pharmaceuticals, Inc., Miami | DERIVED COMPOSITIONS |
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
WO2005025549A2 (en) * | 2003-09-10 | 2005-03-24 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
US20070191815A1 (en) | 2004-09-13 | 2007-08-16 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
US20070148218A1 (en) * | 2003-11-18 | 2007-06-28 | Gordon Ryan D | Olanzapine containing transdermal drug delivery compositions |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
WO2006041911A2 (en) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Device transdermal administration of drugs including acrylic polymers |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
KR100764679B1 (en) * | 2005-07-22 | 2007-10-09 | 익수제약 주식회사 | Patches comprising paroxetine for transdermal application |
BRPI0619806A2 (en) * | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | abuse resistant transmucosal drug delivery device |
DE102006026060B4 (en) * | 2006-01-12 | 2013-01-31 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing as active ingredient nicotine and method for producing such systems |
WO2007112285A2 (en) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Process for the preparation of a hot-melt extruded laminate |
WO2007112287A2 (en) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Hme transdermal compositions containing testosterone |
CA2932389A1 (en) | 2006-03-24 | 2007-10-04 | Auxilium International Holdings, Inc. | Stabilized compositions containing alkaline labile drugs |
US20100015183A1 (en) | 2006-07-21 | 2010-01-21 | Bio Delivery Sciences International ,Inc. | Transmucosal delivery devices with enhanced uptake |
US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
US20100210792A1 (en) * | 2006-12-05 | 2010-08-19 | David Taft | Drug delivery |
US8246978B2 (en) * | 2007-07-10 | 2012-08-21 | Agile Therapeutics, Inc. | Dermal delivery device with reduced loss of its volatile components |
WO2009026135A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
WO2009026133A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Transdermal bisoprolol delivery system |
US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
DE102008013701A1 (en) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with stabilized membrane |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
AU2009300184A1 (en) * | 2008-09-30 | 2010-04-08 | Teikoku Pharma Usa, Inc. | Transdermal extended-delivery donepezil compositions and methods for using the same |
NZ591834A (en) | 2008-10-02 | 2011-12-22 | Mylan Inc | Method of making a multilayer adhesive laminate |
JP5706882B2 (en) * | 2009-04-17 | 2015-04-22 | スリーエム イノベイティブ プロパティズ カンパニー | Silicone gel adhesive composition |
KR101670379B1 (en) * | 2009-07-31 | 2016-10-28 | (주)씨엘팜 | Nicotine transdermal delivery patch |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | Compositions and methods for treatment of symptoms in parkinson's disease patients |
WO2013026064A1 (en) | 2011-08-18 | 2013-02-21 | Biodelivery Sciences International, Inc. | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
FR2987561B1 (en) * | 2012-03-02 | 2014-04-11 | Pf Medicament | TRANSDERMIC DEVICE COMPRISING POROUS MICRO PARTICLES |
WO2014062494A1 (en) * | 2012-10-15 | 2014-04-24 | Noven Pharmaceuticals, Inc. | Compositions and methods for the transdermal delivery of methylphenidate |
CA2889452C (en) | 2012-10-25 | 2016-09-13 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine |
CN103845220B (en) * | 2012-12-04 | 2017-09-01 | 日绊株式会社 | Adhesive preparation |
US9295726B2 (en) | 2012-12-28 | 2016-03-29 | Noven Pharamceuticals, Inc. | Multi-polymer compositions for transdermal drug delivery |
US9314470B2 (en) | 2012-12-28 | 2016-04-19 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
CA2896055C (en) * | 2012-12-28 | 2021-02-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
JP6550337B2 (en) * | 2012-12-28 | 2019-07-24 | ノーヴェン ファーマシューティカルズ インコーポレイテッド | Compositions and methods for transdermally delivering non-steroidal anti-inflammatory agents |
US20140276483A1 (en) * | 2013-03-14 | 2014-09-18 | Noven Pharmaceuticals, Inc. | Transdermal methylphenidate compositions with acrylic block copolymers |
WO2014159582A1 (en) | 2013-03-14 | 2014-10-02 | Noven Pharmaceuticals, Inc | Amphetamine transdermal compositions with acrylic block copolymer |
AR095259A1 (en) | 2013-03-15 | 2015-09-30 | Noven Pharma | COMPOSITIONS AND METHODS FOR THE TRANSDERMAL ADMINISTRATION OF TERTIARY AMINE DRUGS |
AR095260A1 (en) | 2013-03-15 | 2015-09-30 | Noven Pharma | COMPOSITIONS OF STABLE TRANSDERMAL AMPHETAMINS AND MANUFACTURING METHODS |
CN103432104B (en) * | 2013-08-09 | 2015-10-28 | 大连理工大学 | A kind of transdermal patch containing pramipexole |
WO2015054061A1 (en) * | 2013-10-07 | 2015-04-16 | Teikoku Pharma Usa, Inc. | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
CA2924233C (en) | 2013-10-07 | 2018-10-23 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions |
KR20160096155A (en) * | 2013-12-12 | 2016-08-12 | 히사미쓰 세이야꾸 가부시키가이샤 | Patch with cover member and patch kit with cover member |
EP3086783B1 (en) * | 2013-12-23 | 2018-08-29 | Noven Pharmaceuticals, INC. | Compositions and methods for transdermal delivery of amphetamine |
US20160030362A1 (en) | 2014-07-31 | 2016-02-04 | Noven Pharmaceuticals, Inc. | Silicone-containing acrylic polymers for transdermal drug delivery compositions |
WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
WO2016123418A1 (en) | 2015-01-29 | 2016-08-04 | Dow Corning Corporation | Silicone acrylate compositions and methods of preparing the same |
CN107532050B (en) | 2015-02-06 | 2021-03-02 | 诺芬药品公司 | Pressure sensitive adhesive for transdermal drug delivery |
US10406116B2 (en) | 2015-02-06 | 2019-09-10 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
US10679516B2 (en) | 2015-03-12 | 2020-06-09 | Morningside Venture Investments Limited | Craving input and support system |
KR101897174B1 (en) | 2016-08-17 | 2018-09-12 | (주)오스힐 | Transdermal drug delivery promoting apparatus for treatment of soft tissue diseases |
WO2018067163A1 (en) * | 2016-10-07 | 2018-04-12 | Transwell Biotech Co., Ltd. | Pramipexole transdermal delivery system and uses thereof |
BR112019012573A2 (en) | 2016-12-20 | 2019-11-19 | Lts Lohmann Therapie Systeme Ag | transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
MX2019007391A (en) | 2016-12-20 | 2019-08-16 | Lts Lohmann Therapie Systeme Ag | Transdermal therapeutic system containing asenapine. |
KR20190122205A (en) * | 2016-12-29 | 2019-10-29 | 퓨어 래티오스 홀딩스, 인크. | Modular transdermal delivery systems, and related methods of manufacture and use |
AU2018205529B2 (en) | 2017-01-06 | 2023-08-10 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
ES2881783T3 (en) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic polymer |
JP7420797B2 (en) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | Drug delivery methods and systems |
KR20210022656A (en) | 2018-06-20 | 2021-03-03 | 에르테에스 로만 테라피-시스테메 아게 | Transdermal treatment system containing acenapine |
WO2020092990A1 (en) * | 2018-11-02 | 2020-05-07 | Eastern Virginia Medical School | Pharmaceutical compositions and methods of making a patch formulation for transdermal delivery |
WO2021022033A1 (en) | 2019-07-30 | 2021-02-04 | Leung Kai P | Layered composite for scar treatment and prevention |
US11559501B2 (en) | 2021-01-07 | 2023-01-24 | Noven Pharmaceuticals, Inc. | Transdermal amphetamine compositions with low levels of carbamate |
AR124578A1 (en) | 2021-01-07 | 2023-04-12 | Noven Pharma | AMPHETAMINE CARBAMATE COMPOUNDS AND RELATED METHODS |
WO2023240478A1 (en) * | 2022-06-15 | 2023-12-21 | Dow Silicones Corporation | Peelable coating composition and use thereof |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843368B2 (en) | 1980-10-30 | 1983-09-27 | 日東電工株式会社 | Anti-inflammatory analgesic patch |
GB2105990B (en) | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
US4559222A (en) | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4655767A (en) | 1984-10-29 | 1987-04-07 | Dow Corning Corporation | Transdermal drug delivery devices with amine-resistant silicone adhesives |
US4584355A (en) | 1984-10-29 | 1986-04-22 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I |
US4585836A (en) | 1984-10-29 | 1986-04-29 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II |
US4591622A (en) | 1984-10-29 | 1986-05-27 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product thereof |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US4911707A (en) | 1987-02-13 | 1990-03-27 | Ciba-Geigy Corporation | Monolithic user-activated transdermal therapeutic system |
US4746515A (en) | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US4983395A (en) | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4915950A (en) | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4994278A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US4994267A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
DE3905050A1 (en) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE SUBSTANCES (II) |
US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
US5271940A (en) | 1989-09-14 | 1993-12-21 | Cygnus Therapeutic Systems | Transdermal delivery device having delayed onset |
JPH06505712A (en) * | 1990-11-28 | 1994-06-30 | サノ・コーポレーシヨン | Methods and devices for treating tobacco poisoning |
US5633009A (en) | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
JP2960832B2 (en) | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | Estradiol administration system |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
US5462746A (en) * | 1992-11-02 | 1995-10-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
JP2569396B2 (en) * | 1992-12-04 | 1997-01-08 | 株式会社太平洋 | Transdermal drug patch |
DK0813865T3 (en) | 1993-04-20 | 2001-11-19 | Hexal Ag | Plastics with active substance |
US5762952A (en) | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
US5567488A (en) | 1993-09-16 | 1996-10-22 | The Dow Chemical Company | Multilayer barrier film for transdermal drug delivery system and ostomy applications |
DE4332094C2 (en) | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Active substance plaster which can be produced without solvent and process for its preparation |
US5723145A (en) * | 1993-09-30 | 1998-03-03 | Takiron Co., Ltd. | Transdermal absorption preparation |
DE4405898A1 (en) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermal therapeutic systems containing sex steroids |
US5474787A (en) | 1994-10-21 | 1995-12-12 | The Wm. Wrigley Jr. Company | Chewing gum containing a lecithin/glycerol triacetate blend |
FR2728463A1 (en) * | 1994-12-21 | 1996-06-28 | Lhd Lab Hygiene Dietetique | TRANSDERMIC SYSTEM FOR SIMULTANEOUS DELIVERY OF SEVERAL ACTIVE PRINCIPLES |
NZ309980A (en) | 1995-06-07 | 2001-06-29 | Noven Pharma | Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature |
US5906830A (en) | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
US5902603A (en) | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
FR2749586B1 (en) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS |
AU5977598A (en) * | 1997-02-07 | 1998-08-26 | Synapse Pharmaceutical International, Inc. | Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
DE19738855C2 (en) | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermal therapeutic system with adhesive reservoir layer and unidirectional elastic back layer |
DE69833000T2 (en) | 1997-09-26 | 2006-09-07 | Noven Pharmaceuticals, Inc., Miami | BIO-ADHESIVE COMPOSITIONS |
US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
JP2002531488A (en) * | 1998-12-07 | 2002-09-24 | エラン コーポレーシヨン ピーエルシー | Transdermal patches for delivering volatile liquid drugs |
EP1449527A3 (en) | 1998-12-07 | 2004-09-08 | Elan Pharma International Limited | Transdermal patch for administering a volatile liquid drug |
US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
KR20010036685A (en) | 1999-10-11 | 2001-05-07 | 김윤 | Transdermal fentanyl delivery matrix system |
DE19950066A1 (en) | 1999-10-16 | 2001-04-26 | Lohmann Therapie Syst Lts | Transdermal therapeutic system based on polyacrylate matrix carrier comprises tulobuterol hydrochloride |
CA2391430C (en) * | 1999-11-24 | 2009-10-06 | Agile Therapeutics, Inc. | Improved transdermal contraceptive delivery system and process |
ATE324563T1 (en) | 2000-09-24 | 2006-05-15 | 3M Innovative Properties Co | DRYING PROCESS FOR SELECTIVE REMOVAL OF VOLATILE COMPONENTS FROM WET COATINGS |
US6828351B2 (en) * | 2000-11-01 | 2004-12-07 | Sention, Inc. | Methods and compositions for regulating memory consolidation |
US6448303B1 (en) | 2000-12-29 | 2002-09-10 | National Starch And Chemical Investment Holding Corporation | Hot melt adhesives for dermal application |
JP4323138B2 (en) | 2002-06-05 | 2009-09-02 | 日東電工株式会社 | Transdermal preparation and method for producing the same |
WO2005025549A2 (en) | 2003-09-10 | 2005-03-24 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
-
2004
- 2004-10-28 US US10/975,043 patent/US8703175B2/en active Active
- 2004-10-28 RS YUP-2006/0332A patent/RS20060332A/en unknown
- 2004-10-28 BR BRPI0416063-0A patent/BRPI0416063A/en not_active Application Discontinuation
- 2004-10-28 GE GEAP20049414A patent/GEP20084561B/en unknown
- 2004-10-28 ME MEP-235/08A patent/MEP23508A/en unknown
- 2004-10-28 ES ES04810038.2T patent/ES2626784T3/en active Active
- 2004-10-28 ME MEP-2008-235A patent/ME00114B/en unknown
- 2004-10-28 EP EP04810038.2A patent/EP1682061B1/en active Active
- 2004-10-28 KR KR1020067010411A patent/KR20060114338A/en not_active Application Discontinuation
- 2004-10-28 CN CNB2004800392144A patent/CN100457064C/en not_active Expired - Fee Related
- 2004-10-28 JP JP2006538197A patent/JP2007509951A/en active Pending
- 2004-10-28 RU RU2006118341/15A patent/RU2356580C2/en not_active IP Right Cessation
- 2004-10-28 UA UAA200605792A patent/UA84303C2/en unknown
- 2004-10-28 WO PCT/US2004/035556 patent/WO2005042055A2/en active Application Filing
- 2004-10-28 NZ NZ546992A patent/NZ546992A/en not_active IP Right Cessation
- 2004-10-28 AU AU2004285505A patent/AU2004285505B2/en not_active Ceased
- 2004-10-28 CA CA2542778A patent/CA2542778C/en active Active
-
2006
- 2006-04-10 IL IL174894A patent/IL174894A0/en unknown
- 2006-04-25 ZA ZA200603300A patent/ZA200603300B/en unknown
- 2006-05-29 NO NO20062434A patent/NO20062434L/en not_active Application Discontinuation
-
2010
- 2010-06-03 US US12/792,940 patent/US20100310610A1/en not_active Abandoned
-
2013
- 2013-07-31 JP JP2013159844A patent/JP2013237691A/en active Pending
-
2014
- 2014-02-27 US US14/191,900 patent/US20140243764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013237691A (en) | 2013-11-28 |
CN1901861A (en) | 2007-01-24 |
MEP23508A (en) | 2010-06-10 |
US8703175B2 (en) | 2014-04-22 |
CA2542778C (en) | 2012-05-29 |
EP1682061A2 (en) | 2006-07-26 |
WO2005042055A2 (en) | 2005-05-12 |
US20050169977A1 (en) | 2005-08-04 |
ES2626784T3 (en) | 2017-07-26 |
EP1682061A4 (en) | 2011-12-07 |
AU2004285505B2 (en) | 2010-12-23 |
US20100310610A1 (en) | 2010-12-09 |
ZA200603300B (en) | 2007-07-25 |
NZ546992A (en) | 2009-07-31 |
RS20060332A (en) | 2008-04-04 |
NO20062434L (en) | 2006-07-14 |
KR20060114338A (en) | 2006-11-06 |
ME00114B (en) | 2011-02-10 |
WO2005042055A3 (en) | 2005-08-25 |
AU2004285505A1 (en) | 2005-05-12 |
RU2356580C2 (en) | 2009-05-27 |
CN100457064C (en) | 2009-02-04 |
CA2542778A1 (en) | 2005-05-12 |
UA84303C2 (en) | 2008-10-10 |
US20140243764A1 (en) | 2014-08-28 |
RU2006118341A (en) | 2007-12-20 |
IL174894A0 (en) | 2006-08-20 |
EP1682061B1 (en) | 2017-03-15 |
GEP20084561B (en) | 2008-12-10 |
JP2007509951A (en) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0416063A (en) | transdermally drug delivery composition, method of producing the transdermally drug delivery composition and flow control method of a medicament of a dermal drug delivery composition | |
US7731983B2 (en) | Method and composition for the treatment of scars | |
Lehmann et al. | Transdermal fentanyl: clinical pharmacology | |
Ourique et al. | Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine | |
US5415866A (en) | Topical drug delivery system | |
US7316817B2 (en) | Method and device for topical delivery of therapeutic agents to the skin | |
CA2375643C (en) | Exothermic topical delivery device | |
ATE288743T1 (en) | PHARMACEUTICAL CARRIER DEVICE SUITABLE FOR ADMINISTRATION OF ACTIVE INGREDIENTS TO MUCOUS SKIN SURFACES | |
US20090042950A1 (en) | Transdermal topical composition and its uses | |
BR9815378A (en) | A transdermal drug delivery system for an anti-inflammatory analgesic agent comprising diethylammonium salt diclofenac and the method of manufacturing it. | |
AU4923500A (en) | Device and method for increasing the transdermal permeation of medicaments | |
BRPI0510760A (en) | method for administering to a patient a composition, topical composition, and patch | |
BRPI0417437A (en) | absorption inhibiting device, physiologically active agent removal device and overdose reduction device | |
WO2004030743A3 (en) | Drug delivery device having coated microprojections incorporating vasoconstrictors | |
US20040126418A1 (en) | Transdermal administration of MENT | |
CN104271160A (en) | Topical formulation compositions containing silicone based excipients to deliver actives to a substrate | |
US8591940B2 (en) | Method of treating scar tissue | |
BRPI0411032A (en) | hydrophilic adhesive composition, medical article, method for manufacturing the adhesive composition, and transdermal delivery device | |
US20130224280A1 (en) | Transdermal compositions and methods for treating stretch marks | |
US20210275441A1 (en) | Topical skin formulations and wound care products with integrated cbd delivery mechanisms | |
JP2002284701A (en) | Patch for topical treatment of acne | |
US20200345992A1 (en) | Hydrogen-enhanced transdermal system | |
US20100104614A1 (en) | Providone compositions for wound healing | |
Gohil et al. | Current surgical patches and novel wound closure techniques | |
Shankar et al. | Patches: A Novel approach for development of topical drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |